Nakamoto Y - Search Results

1

Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.

Ito T, Hijioka S, Masui T, Kasajima A, Nakamoto Y, Kobayashi N, Komoto I, Hijioka M, Lee L, Igarashi H, Jensen RT, Imamura M. Ito T, et al. Among authors: nakamoto y. J Gastroenterol. 2017 Jan;52(1):9-18. doi: 10.1007/s00535-016-1250-9. Epub 2016 Aug 18. J Gastroenterol. 2017. PMID: 27539256 Review.

2

[Clinical evaluation of TPA-assay kit using monoclonal antibodies].

Saga T, Sakahara H, Kousaka T, Yao Z, Nakamoto Y, Hattori N, Zhang M, Nakayama M, Ohshio G, Imamura M, Konishi J. Saga T, et al. Among authors: nakamoto y. Gan To Kagaku Ryoho. 1996 Apr;23(5):615-21. Gan To Kagaku Ryoho. 1996. PMID: 8678521 Clinical Trial. Japanese.

3

FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, Honda T, Inokuma T, Katsushima S, Ohshio G, Imamura M, Konishi J. Higashi T, et al. Among authors: nakamoto y. J Nucl Med. 1998 Oct;39(10):1727-35. J Nucl Med. 1998. PMID: 9776278 Free article.

4

Contribution of PET in the detection of liver metastases from pancreatic tumours.

Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Imamura M, Konishi J. Nakamoto Y, et al. Clin Radiol. 1999 Apr;54(4):248-52. doi: 10.1016/s0009-9260(99)91160-1. Clin Radiol. 1999. PMID: 10210345

5

Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.

Higashi T, Sakahara H, Torizuka T, Nakamoto Y, Kanamori S, Hiraoka M, Imamura M, Nishimura Y, Tamaki N, Konishi J. Higashi T, et al. Among authors: nakamoto y. J Nucl Med. 1999 Sep;40(9):1424-33. J Nucl Med. 1999. PMID: 10492360 Free article. Clinical Trial.

6

Autoimmune pancreatitis with F-18 fluoro-2-deoxy-D-glucose PET findings.

Nakamoto Y, Sakahara H, Higashi T, Saga T, Sato N, Okazaki K, Imamura M, Konishi J. Nakamoto Y, et al. Clin Nucl Med. 1999 Oct;24(10):778-80. doi: 10.1097/00003072-199910000-00009. Clin Nucl Med. 1999. PMID: 10512104

7

Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities.

Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Itoh K, Imamura M, Konishi J. Nakamoto Y, et al. Clin Nucl Med. 2000 Feb;25(2):115-9. doi: 10.1097/00003072-200002000-00007. Clin Nucl Med. 2000. PMID: 10656646

8

Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.

Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, Hosotani R, Imamura M, Konishi J. Nakamoto Y, et al. Cancer. 2000 Dec 15;89(12):2547-54. doi: 10.1002/1097-0142(20001215)89:12<2547::aid-cncr5>3.0.co;2-v. Cancer. 2000. PMID: 11135214 Clinical Trial.

9

FDG-PET of autoimmune-related pancreatitis: preliminary results.

Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, Imamura M, Sakahara H, Konishi J. Nakamoto Y, et al. Eur J Nucl Med. 2000 Dec;27(12):1835-8. doi: 10.1007/s002590000370. Eur J Nucl Med. 2000. PMID: 11189947

10

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, Doi R, Hosotani R, Imamura M, Konishi J. Higashi T, et al. Among authors: nakamoto y. J Nucl Med. 2002 Feb;43(2):173-80. J Nucl Med. 2002. PMID: 11850481 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

862 results

Search Page